Science & studies 4.1 Key publications Before going into the details of the individual studies, here are 6 key publications on which the BPC-157 evidence base rests: Sikiric P., Seiwerth S., Rucman R., et al
Liraglutide, the active comparator, was initiated at 0.6 mg daily and titrated weekly up to 3.0 mg
From receptor pharmacology and weight loss percentages to gastrointestinal side effects and body composition changes, every comparison here draws from published clinical trial data
The second line appears in more recent applications for unit formulations for peptides
Rights and permissions About this article Cite this article Czonkowska, A., Litwin, T., Dusek, P
Delta SleepInducing Peptide (DSIP) directly targets hypothalamic sleep centers, increasing deltawave activity, shortening sleep latency, and modulating nighttime cortisol spikes